Literature DB >> 18140660

Plasma and red cell radioiron following intravenous injection; turpentine abscesses in normal and anemic dogs.

C L YUILE, C G BLY.   

Abstract

Sterile inflammation induced by repeated subcutaneous injections of turpentine in non-anemic, non-iron-deficient dogs, leads to a fall in plasma iron concentration, the development of a moderate anemia, and a marked delay in the uptake by the red blood cells of intravenous radioiron. Similar periods of inflammation in anemic, iron-deficient dogs on a diet low in iron cause no increase in the degree of anemia and no inhibition of red blood cell uptake of intravenous radioiron. Radioiron appears only in traces in abscess exudates. Intravenous iron disappearance curves following a single injection are uninfluenced by sterile inflammation in either anemic or non-anemic dogs. The impairment of hemoglobin synthesis caused by inflammation is at most a relative matter, since the anemia that develops is seldom severe or progressive, and since the inhibition can be overcome if the marrow is sufficiently stimulated by the demands of a severe continuing anemia.

Entities:  

Keywords:  BLOOD/iron; RADIOACTIVE SUBSTANCES/iron; TURPENTINE/toxicity

Mesh:

Substances:

Year:  1949        PMID: 18140660      PMCID: PMC2135918          DOI: 10.1084/jem.90.4.273

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  CIRCULATING RED CELL VOLUME MEASURED SIMULTANEOUSLY BY THE RADIOACTIVE IRON AND DYE METHODS.

Authors:  J G Gibson; W C Peacock; A M Seligman; T Sack
Journal:  J Clin Invest       Date:  1946-11       Impact factor: 14.808

2.  THE ANEMIA OF INFECTION. IV. THE LACK OF RELATIONSHIP BETWEEN THE DIVERSION OF IRON FROM THE PLASMA AND THE ORIGIN OF THE ANEMIA.

Authors:  G R Greenberg; H Ashenbrucker; M Lauritsen; M M Wintrobe
Journal:  J Clin Invest       Date:  1947-01       Impact factor: 14.808

3.  CLINICAL STUDIES OF THE BLOOD VOLUME. IV. ADAPTATION OF THE METHOD TO THE PHOTOELECTRIC MICROCOLORIMETER.

Authors:  J G Gibson; K A Evelyn
Journal:  J Clin Invest       Date:  1938-03       Impact factor: 14.808

4.  The effect of oral therapy with cobaltous chloride on the blood of patients suffering with chronic suppurative infection.

Authors:  J C ROBINSON; G W JAMES; R M KARK
Journal:  N Engl J Med       Date:  1949-05-12       Impact factor: 91.245

5.  INFECTION AND INTOXICATION : THEIR INFLUENCE UPON HEMOGLOBIN PRODUCTION IN EXPERIMENTAL ANEMIA.

Authors:  F S Robscheit-Robbins; G H Whipple
Journal:  J Exp Med       Date:  1936-04-30       Impact factor: 14.307

6.  RED CELL AND PLASMA VOLUMES (CIRCULATING AND TOTAL) AS DETERMINED BY RADIO IRON AND BY DYE.

Authors:  P F Hahn; J F Ross; W F Bale; W M Balfour; G H Whipple
Journal:  J Exp Med       Date:  1942-01-31       Impact factor: 14.307

  6 in total
  5 in total

1.  [Experimental and clinical studies on pregnancy sideropenia with a radioactive iron complex].

Authors:  H A KUNKEL; H MAASS; H J SCHMERMUND; H GOLDECK
Journal:  Klin Wochenschr       Date:  1954-09-15

2.  Passage of radioactive erythrocytes from the peritoneal cavity into the blood stream during experimental ascites.

Authors:  F W McKEE; W B STEWART
Journal:  J Exp Med       Date:  1950-06-01       Impact factor: 14.307

3.  Radioiron absorption in anemic dogs; fluctuations in the mucosal block and evidence for a gradient of absorption in the gastrointestinal tract.

Authors:  W B STEWART; C L YUILE; H A CLAIBORNE; R T SNOWMAN; G H WHIPPLE
Journal:  J Exp Med       Date:  1950-10-01       Impact factor: 14.307

4.  Age as effecting the osmotic and mechanical fragility of dog erythrocytes tagged with radioactive iron.

Authors:  W B STEWART; J M STEWART
Journal:  J Exp Med       Date:  1950-02       Impact factor: 14.307

5.  Plasma iron and saturation of plasma iron-binding protein in dogs as related to the gastro-intestinal absorption of radioiron.

Authors:  C L YUILE; J W HAYDEN; J A BUSH; H TESLUK; W B STEWART
Journal:  J Exp Med       Date:  1950-10-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.